Sept 3 (Reuters) – Moderna Inc said on Friday it had asked the EU drugs regulator for conditional approval of a booster shot of its COVID-19 vaccine at a 50 microgram dose.
The company also said it had completed data submission for the use of a third booster dose of its two-shot vaccine to the U.S. Food and Drug Administration.
Moderna said clinical study data and additional analyzes showed that a 50-microgram booster dose of its COVID-19 vaccine induces robust antibody responses against the Delta variant. The company’s original vaccine contains 100 micrograms of mRNA in each shot.
The submissions come as several countries, including the United States, are already offering or have plans to give booster doses of COVID-19 vaccines to the vulnerable or those with weak immune systems amid the spread of the highly contagious Delta variant.
The European Centre for Disease Prevention and Control (ECDC) earlier this week said there was no urgent need for booster doses of COVID-19 vaccines for the fully vaccinated.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)
On July 23, 2025, Ascension Leadership Academy (ALA) announced the launch of a 14-day fundraising…
On Tuesday, at the Jury Assembly Plaza, the Harris County District Clerk Office unveiled its…
US Representative Sheila Jackson Lee and Texas State Sen. John Whitmire will face a December…
As Houstonians head to the polls to elect a new mayor and representatives to city…
Texas is the second-most-insecure state in the US, meaning that the population of the state…
Texas sued the Biden administration as an effort to stop federal agents from cutting the…